top of page

SmartHeart®

A human-relevant fully integrated cardiac model to identify safer and more effective molecules.

SmartHeart comparison

SmartHeart captures what hERG and 2D don't see.

3-in-1 3D cardiac assay replicating key in vivo mechanisms

The SmartHeart is an integrated solution to measure contractility (1), action potential (2), and calcium handling (3).This streamlined approach minimizes variability, delivering unmatched insights into in vivo toxic mechanisms

CONTRACTILITY (1)

Background list

Contractility Metrics

​

Frequency

Contraction stress

​Contraction strain

Contraction speed

Relaxation speed

​

Drug cardiac tropism​

 

Chronotropic

Inotropic​

 

Chronotropic

Lusitropic

ELECTROPHYSIOLOGY (2)

Background list

Action potential Metrics

​​

Frequency

Interpeak duration STD Rising time, Upstroke velocity

APD10-90

Triangulation, Plateau phase

Electrophysiology features

​​

Rhythm

Regularity Depolarization

 

Impacted channels Proarrhythmia

CALCIUM TRANSIENTS (3)

Background list

CaT Metrics

​​

Frequency

Interpeak duration STD Amplitude

Area Under curve ‘Rise and decay’ duration and speeds

CD10,50,90

Comprehensive understanding of calcium dynamics in tissues

 3-in-1 3D cardiac assay replicating key in vivo mechanisms

Brightfield - Contractility

FluoVolt - membrane action potential

CAL520 - Calcium transient

UNPRECEDENT FEATURES​

HUMAN HEART TISSUES

HUMAN HEART TISSUES

hiPSC-CMs and cardiac fibroblast

HIGH THROUGHPUT

HIGH THROUGHPUT

96-well plate

Picto-Post-ICH7B-ready.png

FULLY INTEGRATED MODEL

Coupled contractility, electrophysiology, and calcium readouts 

EASY TO USE

SELF-ASSEMBLY / EASY TO USE +++

Plate your cells, let them beat, measure

7200 CELLS PER TISSUE

7200 CELLS:TISSUE

3:1 ratio of cardiomyocytes to fibroblasts

Picto-High-statistical-power.png

HIGH STATISTICAL POWER

9 tissues/replicates per well

HIGH RESOLUTION IMAGING

HIGH RESOLUTION IMAGING

Glass bottom plate

IN SITU CHARACTERIZATION

IN SITU CHARACTERIZATION

Multiple key readouts in a single assay

SMARTHEART CAPITALIZE ON THE HIGHEST STANDARDS

A human-like cardiac model engineered to reach a high level of maturation

SmartHeart® tissues offer enhanced morphological, structural, molecular, and functional maturity, increasing the predictability of cardiotoxicity studies and clearly surpassing the limitations of traditional 2D approaches.

3D modelisation of the 4Dcell SmartHeart

3D reconstruction of a ring. Vimentin (green), Troponin T (red) and DAPI (blue)

Sarcomeres observed in the SmartHeart

Immunostained contractile fibers at 63X magnification. Troponin T (red) and DAPI (blue) – Seguret & al.

MORPHOLOGY

The ring-shaped geometry allows for a more physiologically accurate distribution of forces within the tissue. It facilitates the visualization of re-entrant waves, which are responsible for most clinical arrhythmias.

STRUCTURE

The SmartHeart® platform provides structurally mature tissues featuring well-aligned contractile fibers and sarcomeres.

RT-qPCR data highlighting the upregulation of key genes for cardiac function with the SmartHeart compared to 2D models

MOLECULAR EXPRESSION

RT-qPCR data highlight the upregulation of key genes for cardiac function compared to 2D models.

Direct measurement of positive and negative inotropy, what 2D and CHO can't give you

Inotropy, the modulation of cardiac contractile force, is a key efficacy and safety signal that conventional hERG, CHO, and 2D hiPSC-CM assays cannot measure. SmartHeart® quantifies it directly through contraction strain in 3D human cardiac tissue, capturing both positive and negative inotropy with statistical confidence.

Positive inotropes

Negative inotropes

Isoprenaline.jpg
Bay-K.jpg
Metoprolol.jpg

Why it matters: SmartHeart® detects negative inotropy driven at the ion-channel level, mirroring the cardiodepressant effect of dihydropyridine calcium blockers.

Why it matters: The canonical positive-inotropy benchmark confirms a physiological β-adrenergic response with a clean dose-response.

Why it matters: Detects inotropy driven at the ion-channel level, with statistical significance even at the lowest concentration tested

Omecantiv.jpg

Why it matters: A myotrope that raises the calcium transient, invisible to calcium- or voltage-only assays, but clearly resolved by SmartHeart®'s direct force readout.

Istaroxime.jpg

Why it matters: Captures calcium-handling-based inotropy, the mechanism of next-generation heart-failure therapeutics.

Nifedipine.jpg

Why it matters: a receptor-level negative inotrope, confirming that SmartHeart® captures the full bidirectional inotropic spectrum.

CiPA Panel High-fidelity cardiac safety assessments

SmartHeart® reliably replicates the electrophysiological responses (via optical mapping assessment) to CiPA panel drugs, ensuring high-fidelity cardiac safety assessments.

HIGH TDP RISK

High TDP risk CiPA drug tested on the 4Dcell SmartHeart

LOW TDP RISK

Low TDP risk CiPA drug tested on the 4Dcell SmartHeart

ENGINEERED 3D HUMAN CARDIAC MODEL 

SmartHeart action principle

PACE X  WELL-BY-WELL STIMULATION SYSTEM

Unpaced

1.5 Hz

2 Hz

2.5 Hz

Precision & Consistency of Stimulation
Well-by-well pacing ensures each well receives the exact same stimulus, eliminating variability caused by spontaneous beating or uneven stimulation. This leads to cleaner signals, reduces experimental noise, and minimizes artifacts due to differences in cell behavior or plating, ultimately improving data quality and assay reliability.


Improved assay reproducibility
Standardized pacing minimizes discrepancies between wells, improving intra- and inter-plate reproducibility.

Multiplexing of conditions
Different compounds, cell types, or pacing frequencies can be applied simultaneously in the same plate, ideal for high-throughput screening (HTS).

Synchronization with data acquisition
Timing of contraction events can be aligned with optical or impedance-based readouts, enhancing signal clarity and consistency.

Enhanced model translatability
Regular pacing mimics physiological heart rates, increasing the relevance of the assay for predicting in vivo responses (e.g. inotropic effects, QT prolongation, arrhythmia risk).

Supports cardiomyocyte maturation
Chronic pacing promotes structural and functional maturation of hiPSC-derived cardiomyocytes (sarcomere organization, gene expression, calcium handling).

Enables kinetic or dose-response studies
With consistent pacing, subtle changes in contraction amplitude, duration, or rhythm in response to drugs can be detected with higher sensitivity.

SMARTX 2.0 AI DRIVEN PRECISION FOR YOUR EXPERIMENTS

Bright field videos (e.g. 500x500 pixels, min 35 fps and 10 s length) of the contracting rings can be analyzed using 4Dcell’s SmartExplorer software, SmartX 2.0.

The algorithm uses machine learning to detect and track the area of the central pilar, from which it determines several parameters: contraction amplitude, contraction strain, contraction and relaxation speed, contraction stress, etc.

SMARTX 2.0
SMARTX 2.0

SmartX is an AI-powered image analysis platform engineered to evolve with every experiment you run.

 

At its core lies a deep learning module that continually “learns” from each dataset, refining its ability to detect and track beating rings with ever-greater accuracy and speed. Whether you’re measuring contraction strength, frequency, or spatial consistency, SmartX adapts to your unique imaging conditions and cell patterns, automatically adjusting its segmentation models to reduce false positives and enhance signal fidelity.

 

The result is a self-optimizing workflow that delivers robust, reproducible metrics experiment after experiment, freeing you to focus on biological insights rather than manual analysis.

DO YOU WANT TO PUSH THE LIMITS OF 3D CELL CULTURE? LET'S DISCUSS YOUR PROJECTS

bottom of page